Scolaris Content Display Scolaris Content Display

original image

Figuras y tablas -
Figure 1

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Figuras y tablas -
Figure 2

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Figuras y tablas -
Figure 3

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 1: Global state: clinically important change  ‐ number of participants with clinical response

Figuras y tablas -
Analysis 1.1

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 1: Global state: clinically important change  ‐ number of participants with clinical response

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 2: Adverse effects: clinically important  adverse effects ‐ number of participants with a delayed memory deficit

Figuras y tablas -
Analysis 1.2

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 2: Adverse effects: clinically important  adverse effects ‐ number of participants with a delayed memory deficit

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 3: Cognitive functioning: any change ‐ number of participants with improvement

Figuras y tablas -
Analysis 1.3

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 3: Cognitive functioning: any change ‐ number of participants with improvement

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 4: Cognitive functioning: average change score from baseline to endpoint of RBANS total index (high = good)

Figuras y tablas -
Analysis 1.4

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 4: Cognitive functioning: average change score from baseline to endpoint of RBANS total index (high = good)

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 5: Mental state‐Overall: average change score from baseline to endpoint of PANSS total (high = poor)

Figuras y tablas -
Analysis 1.5

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 5: Mental state‐Overall: average change score from baseline to endpoint of PANSS total (high = poor)

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 6: Mental state‐Positive symptoms: average change score from baseline to endpoint of PANSS positive subscale (high = poor)

Figuras y tablas -
Analysis 1.6

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 6: Mental state‐Positive symptoms: average change score from baseline to endpoint of PANSS positive subscale (high = poor)

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 7: Mental state‐Negative symptoms: change scores of PANSS negative subscale (high = poor)

Figuras y tablas -
Analysis 1.7

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 7: Mental state‐Negative symptoms: change scores of PANSS negative subscale (high = poor)

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 8: Leaving the study early: any reason

Figuras y tablas -
Analysis 1.8

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 8: Leaving the study early: any reason

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 9: Leaving the study early: due to adverse effect

Figuras y tablas -
Analysis 1.9

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 9: Leaving the study early: due to adverse effect

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 10: Leaving the study early: due to inefficacy

Figuras y tablas -
Analysis 1.10

Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 10: Leaving the study early: due to inefficacy

Summary of findings 1. Magnetic seizure therapy plus standard care compared to electroconvulsive therapy plus standard care for people with schizophrenia

Magnetic seizure therapy plus standard care compared to electroconvulsive therapy plus standard care for people with schizophrenia

Patient or population: people with acute schizophrenia
Setting: inpatient
Intervention: magnetic seizure therapy + standard care
Comparison: electroconvulsive therapy + standard care

Outcomes

Anticipated absolute effects* (95% CI)

Relative effect
(95% CI)

№ of participants
(studies)

Certainty of the evidence
(GRADE)

Comments

Risk with electroconvulsive therapy

Risk with magnetic seizure therapy

Global state: clinically important change 
assessed by: number of participants with a clinical response
Study duration: 4 weeks

Study population

RR 1.12
(0.73 to 1.70)

79
(1 RCT)

⊕⊝⊝⊝
Very low 1 2

A clinical response was defined as a ≥ 25% reduction from baseline to the endpoint of the PANSS total score.

472 per 1000

529 per 1000
(345 to 803)

Cognitive functioning: clinically important change ‐ not measured

 

Adverse effects: clinically important adverse effects
assessed by: number of participants with a delayed memory deficit
Study duration: 4 weeks

Study population

RR 0.63
(0.41 to 0.96)

79
(1 RCT)

⊕⊝⊝⊝
Very low 1 3

A delayed memory deficit was defined as a ≥ 10% decrease from baseline to the endpoint of the RBANS delayed memory score.

667 per 1000

420 per 1000
(273 to 640)

Quality of life: clinically important change ‐ not measured

 

Social functioning: clinically important change ‐ not measured

 

Leaving the study early: any reason
assessed by: number of dropouts for any reason

Study duration: 4 weeks

Study population

RR 2.51
(0.73 to 8.59)

79
(1 RCT)

⊕⊝⊝⊝
Very low 1 2

 

83 per 1000

209 per 1000
(61 to 716)

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; OR: odds ratio; PANSS: the Positive and Negative Syndrome Scale; RBANS: the Repeatable Battery for the Assessment of Neuropsychological Status; RR: risk ratio

GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.

1 Downgraded by two levels: high risk of bias in two domains (selective reporting, other bias) and unclear risk in one domain (blinding of participants and personnel).

2 Downgraded by two levels: the optimal information size (OIS) was not met and the confidence interval included both appreciable benefit and harm.

3 Downgraded by one level: OIS was not met.

Figuras y tablas -
Summary of findings 1. Magnetic seizure therapy plus standard care compared to electroconvulsive therapy plus standard care for people with schizophrenia
Comparison 1. Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1.1 Global state: clinically important change  ‐ number of participants with clinical response Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.2 Adverse effects: clinically important  adverse effects ‐ number of participants with a delayed memory deficit Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.3 Cognitive functioning: any change ‐ number of participants with improvement Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.4 Cognitive functioning: average change score from baseline to endpoint of RBANS total index (high = good) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.5 Mental state‐Overall: average change score from baseline to endpoint of PANSS total (high = poor) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.6 Mental state‐Positive symptoms: average change score from baseline to endpoint of PANSS positive subscale (high = poor) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.7 Mental state‐Negative symptoms: change scores of PANSS negative subscale (high = poor) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.8 Leaving the study early: any reason Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.9 Leaving the study early: due to adverse effect Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.10 Leaving the study early: due to inefficacy Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

Figuras y tablas -
Comparison 1. Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care